These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35353163)

  • 21. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
    Archer DF; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Menopause; 2014 Mar; 21(3):227-35. PubMed ID: 23963307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of vaginal administration of conjugated estrogens tablet on sexual function in postmenopausal women with sexual dysfunction: a double-blind, randomized, placebo-controlled trial.
    Bumphenkiatikul T; Panyakhamlerd K; Chatsuwan T; Ariyasriwatana C; Suwan A; Taweepolcharoen C; Taechakraichana N
    BMC Womens Health; 2020 Aug; 20(1):173. PubMed ID: 32787848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
    JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
    Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets.
    Derzko CM; Röhrich S; Panay N
    Menopause; 2020 Oct; 28(2):113-118. PubMed ID: 33038141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
    Serrano D; Gandini S; Thomas P; Crew KD; Kumar NB; Vornik LA; Lee JJ; Veronesi P; Viale G; Guerrieri-Gonzaga A; Lazzeroni M; Johansson H; D'Amico M; Guasone F; Spinaci S; Bertelsen BE; Mellgren G; Bedrosian I; Weber D; Castile T; Dimond E; Heckman-Stoddard BM; Szabo E; Brown PH; DeCensi A; Bonanni B
    JAMA Oncol; 2023 May; 9(5):664-672. PubMed ID: 36951827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial.
    Hunter MM; Guthrie KA; Larson JC; Reed SD; Mitchell CM; Diem SJ; LaCroix AZ; Huang AJ
    J Sex Med; 2020 Jan; 17(1):117-125. PubMed ID: 31812686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.
    Archer DF; Goldstein SR; Simon JA; Waldbaum AS; Sussman SA; Altomare C; Zhu J; Yoshida Y; Schaffer S; Soulban G
    Menopause; 2019 Jan; 26(6):611-621. PubMed ID: 30694917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of estradiol vaginal gel on vaginal atrophy in postmenopausal women: A randomized double-blind controlled trial.
    Tanmahasamut P; Jirasawas T; Laiwejpithaya S; Areeswate C; Dangrat C; Silprasit K
    J Obstet Gynaecol Res; 2020 Aug; 46(8):1425-1435. PubMed ID: 32715556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
    Sánchez-Rovira P; Hirschberg AL; Gil-Gil M; Bermejo-De Las Heras B; Nieto-Magro C
    Oncologist; 2020 Dec; 25(12):e1846-1854. PubMed ID: 32459035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert.
    Mirkin S; Simon JA; Liu JH; Archer DF; Castro PD; Graham S; Bernick B; Komm B
    Menopause; 2021 May; 28(9):998-1003. PubMed ID: 34054104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-Related Changes, Influencing Factors, and Crosstalk Between Vaginal and Gut Microbiota: A Cross-Sectional Comparative Study of Pre- and Postmenopausal Women.
    Yoshikata R; Yamaguchi M; Mase Y; Tatsuzuki A; Myint KZY; Ohta H
    J Womens Health (Larchmt); 2022 Dec; 31(12):1763-1772. PubMed ID: 36374244
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.
    Yaralizadeh M; Abedi P; Najar S; Namjoyan F; Saki A
    Maturitas; 2016 Feb; 84():75-80. PubMed ID: 26617271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
    JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C; Yu SL; Hiemeyer F; Schaefers M
    Climacteric; 2009 Oct; 12(5):419-26. PubMed ID: 19479489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Pueraria mirifica on vaginal artery vascularization in postmenopausal women with genitourinary syndrome of menopause.
    Warinsiriruk P; Tantitham C; Cherdshewasart W; Shobeiri SA; Manonai J
    Maturitas; 2022 Jun; 160():4-10. PubMed ID: 35550707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: A pilot randomized controlled trial.
    Yoshikata R; Yamaguchi M; Mase Y; Tatsuyuki A; Myint KZY; Ohta H
    PLoS One; 2022; 17(12):e0270242. PubMed ID: 36584204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
    Jonasson AF; Edwall L; Uvnäs-Moberg K
    Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.
    Simon JA; Kagan R; Archer DF; Constantine GD; Bernick B; Graham S; Mirkin S
    Climacteric; 2019 Aug; 22(4):412-418. PubMed ID: 30862193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.